Mayumi Nakagawa
August 25, 2021
NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study
Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).
April 27, 2017
UAMS’ Mayumi Nakagawa, M.D., Ph.D., Named Nettleship Chair in Oncologic Pathology
LITTLE ROCK — Mayumi Nakagawa, M.D., Ph.D., was invested April 26 as recipient of the Drs. Mae and Anderson Nettleship Chair in Oncologic Pathology at the University of Arkansas for Medical Sciences (UAMS). She is a professor in the Department of Pathology and Laboratory Sciences in the UAMS College of Medicine and co-leader of the…
May 11, 2016
Donna Gullette Named Outstanding UAMS Woman Faculty Member
May 11, 2016 | Donna Gullette, Ph.D., A.P.R.N., associate dean for practice and professor in the UAMS College of Nursing, received the 2016 Outstanding Woman Faculty Award from the UAMS Women’s Faculty Development Caucus. Gullette, who is also director of the college’s Master of Nursing Science (M.N.Sc.) program, was recognized April 28 at the caucus’…
March 9, 2016
UAMS Researcher’s HPV Vaccine Holds Promise for Saving Lives, Preventing Premature Births
LITTLE ROCK — A human papillomavirus (HPV) vaccine, discovered by a University of Arkansas for Medical Sciences (UAMS) researcher and recently shown to be safe, is being made available to a larger group of Arkansas women for further testing. In her recently completed phase I study involving 34 women, researcher Mayumi Nakagawa, M.D., Ph.D., demonstrated…
February 18, 2016
Cancer Program Focuses on State’s Cancer Disparity Rates
Feb. 18, 2016 | Joseph Su, Ph.D., M.P.H., and Mayumi Nakagawa, M.D., Ph.D., have a big job ahead of them. As co-directors of the Cancer Prevention and Population Sciences (CPPS) program in UAMS’ Winthrop P. Rockefeller Cancer Institute, they are working to solve the problem of cancer disparity in Arkansas. According to the Centers for…
May 9, 2014
Vaccine for Existing HPV, Pre-Cancerous Lesions Shows Promise
A potential breakthrough HPV (human papillomavirus) vaccine for women who already have HPV appears to have passed its first major test for Mayumi Nakagawa, M.D., Ph.D., at the University of Arkansas for Medical Sciences (UAMS).